BGM Group Ltd. (BGM) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)
A side-by-side comparison of BGM Group Ltd. and Corbus Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGM
BGM Group Ltd.
$9.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BGM vs CRBP
growth of $100 · dividends reinvested · last 2yBGM -94.3% (-76.2%/yr)CRBP -90.1% (-68.5%/yr)CRBP compounded faster over this window
BGM CRBP
BGM vs CRBP: by the numbers
- •BGM is the larger company ($119M vs $108M market cap).
- •Both run net losses; CRBP's is the smaller (0.00% vs -52.59% net margin).
Metrics side by side
Valuation
| Metric | BGM | CRBP |
|---|---|---|
| P/B ratio | 0.30 | 1.06 |
Profitability
| Metric | BGM | CRBP |
|---|---|---|
| Gross margin | 12.79% | 0.00% |
| Operating margin | -33.18% | 0.00% |
| Net margin | -52.59% | 0.00% |
| ROE | -5.10% | -99.67% |
| ROIC | -3.19% | -101.30% |
Growth (annualized)
| Metric | BGM | CRBP |
|---|---|---|
| Revenue CAGR (5Y) | -5.39% | N/A |
| Total return CAGR (5Y) | N/A | -28.32% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.